ProBiotix Health Plc

Board/Management Information • Jul 29, 2024

National Storage Mechanism | Additional information

RNS Number : 0810Y

Probiotix Health PLC

29 July 2024

29 July 2024

ProBiotix Health plc

( "ProBiotix" or the "Company")

New appointment

ProBiotix Health p lc (AQUIS: PBX), a life sciences busi ness d eveloping probiotics to support cardiometabolic health, announces it has appointed Cellan Davies as its new Head of Marketing as of 5 July 2024. Cellan's role will be to implement new innovative marketing strategies and enhance customer acquisition efforts.

Through his previous roles with leading global brands such as Lab4 Probiotics by Cultech Ltd and ProVen Probiotics, as well as European companies PRP Supplements and Aliment Nutrition, Cellan has been instrumental in implementing marketing and communication strategies across B2B, B2C and D2C segments within the supplement and nutrition industry. He has worked with ProBiotix for two years in a part time capacity before now transitioning to a fulltime role. He brings more than ten years of commercial and marketing experience in the supplements and nutrition industry, and a specialised focus on probiotics for the past eight years.

Steen Andersen, CEO of ProBiotix Health plc, commented: "We are delighted to have Cellan step into his new role this month, and are already seeing the benefits of his hard work and invaluable experience. As our newly appointed head of marketing, his deep understanding of probiotic science means Cellan is well-equipped to translate complex research into compelling communications for our innovative product portfolio. His energy and passion for probiotic science, combined with his commitment to fostering innovation and driving market expansion strategies, will help to enhance ProBiotix's global market presence."

For further information, please contact:

ProBiotix Health plc	https://probiotixhealth-ir.com/
Steen Andersen, Chief Executive	Contact via Walbrook below
Peterhouse Capital Limited (Aquis Corporate Adviser and Broker)	Tel: 020 7469 0930
Mark Anwyl
Duncan Vasey
Walbrook PR Ltd	[email protected]
Anna Dunphy	Mob: 07876 741 001

About Reach announcements

This is a Reach announcement. Reach is an investor communication service aimed at assisting listed and unlisted (including AIM and AQUIS quoted) companies to distribute media only / non-regulatory news releases into the public domain. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on Reach.

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NRAZQLFLZDLLBBB